TrialPanorama/TrialPanorama-database huggingface dataset:
Study 23158914 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 16205916 — Predictive Biomarker (PRD): LARS1 mRNA
Genes: LARS1; KIAA1352; LARS
Study 30128710 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 24216088 — Predictive Biomarker (PRD): DDC mRNA
Genes: DDC; AADC
Study 22348456 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 22348456 — Surrogate Endpoint (SUR): Blood pressure
Study 20662070 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study 7082501 — Predictive Biomarker (PRD): FGFR1
Genes: H2; H3; H4; H5; CEK; FLG; BFGFR; N-SAM; CD331
Study 7082501 — Surrogate Endpoint (SUR): Blood pressure
Study 18313350 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 16492072 — Surrogate Endpoint (SUR): Blood pressure
Study 27546095 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study 23009189 — Safety Biomarker (SAF): BDNF
Study 18319361 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 18319361 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 15121562 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 26349936 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 22782948 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 22782948 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 22782948 — Predictive Biomarker (PRD): IFNL3 mRNA
Genes: IFNL3; IL28B; IL28C; ZCYTO22
Study 17924894 — Surrogate Endpoint (SUR): Blood pressure
Study 9450712 — Surrogate Endpoint (SUR): Blood pressure
Study 25713485 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 25713485 — Safety Biomarker (SAF): MMP-1
Genes: MMP1
Study 23410871 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23410871 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 3429863 — Surrogate Endpoint (SUR): Blood pressure
Study 26058036 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26058036 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 21094804 — Predictive Biomarker (PRD): CD52 mRNA
Genes: CD52; CDW52; HE5
Study 16837434 — Predictive Biomarker (PRD): LCT mRNA
Genes: LCT; LPH
Study 16837434 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 21176784 — Surrogate Endpoint (SUR): Blood pressure
Study 19237404 — Surrogate Endpoint (SUR): Serum creatinine
Study 15545308 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 514499 — Surrogate Endpoint (SUR): Blood pressure
Study 6414060 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study 20200548 — Surrogate Endpoint (SUR): Blood pressure
Study 15561050 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 15561050 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 15561050 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 15561050 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 15561050 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 27184779 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 22851734 — Surrogate Endpoint (SUR): Blood pressure
Study 22851734 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 11680727 — Surrogate Endpoint (SUR): Blood pressure
Study 23897066 — Surrogate Endpoint (SUR): Blood pressure
Study 11778950 — Predictive Biomarker (PRD): ALAD mRNA
Genes: ALAD
Study 21271232 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 11497192 — Surrogate Endpoint (SUR): Blood pressure
Study 10342793 — Surrogate Endpoint (SUR): Blood pressure
Study 30739130 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30739130 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30739130 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 30739130 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Matrix metalloproteinase 3
Genes: MMP3; STMY1
Study 21170684 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 21170684 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 21170684 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21170684 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 12843690 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 12843690 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 12843690 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 12843690 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 12843690 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 9058443 — Safety Biomarker (SAF): 51Cr-EDTA
Study 25402332 — Predictive Biomarker (PRD): CXCR1 mRNA
Genes: CXCR1; CMKAR1; IL8RA
Study 18555997 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 12556649 — Surrogate Endpoint (SUR): Blood pressure
Study 30172703 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 10647267 — Surrogate Endpoint (SUR): Bone mineral density
Study 1659437 — Surrogate Endpoint (SUR): Blood pressure
Study 31593582 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 29326577 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 29326577 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 29326577 — Safety Biomarker (SAF): BDNF
Study 14671247 — Surrogate Endpoint (SUR): Blood pressure
Study 1568727 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 1568727 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 21428467 — Safety Biomarker (SAF): Reactive oxygen species
Study 6497936 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 25795947 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25795947 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 16397167 — Safety Biomarker (SAF): MTHFR
Study 16397167 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 14534519 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study 10591840 — Surrogate Endpoint (SUR): Bone mineral density
Study 345380 — Surrogate Endpoint (SUR): Blood pressure
Study 17893252 — Predictive Biomarker (PRD): GAL3ST1 mRNA
Genes: GAL3ST1; CST
Study 15717651 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 15717651 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study 25582305 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 8512761 — Surrogate Endpoint (SUR): Blood pressure
Study 18515735 — Surrogate Endpoint (SUR): Bone mineral density
Study 8185690 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 8185690 — Surrogate Endpoint (SUR): Serum creatinine
Study 25886031 — Surrogate Endpoint (SUR): Blood pressure
Study 21365126 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 9682339 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 25963237 — Surrogate Endpoint (SUR): Bone mineral density
Study 11170993 — Predictive Biomarker (PRD): SLPI mRNA
Genes: SLPI; WAP4; WFDC4
Study 8847042 — Monitoring Biomarker (MOI): HBV DNA
Study 21087072 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 18679152 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31444404 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study 31444404 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 11
Genes: CXCL11; ITAC; SCYB11; SCYB9B
Study 31444404 — Predictive Biomarker (PRD): CCL20 mRNA
Genes: CCL20; LARC; MIP3A; SCYA20
Study 20881341 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study 19020142 — Safety Biomarker (SAF): Reactive oxygen species
Study 12895219 — Monitoring Biomarker (MOI): HBV DNA
Study 10695778 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 29543887 — Surrogate Endpoint (SUR): Bone mineral density
Study 8915932 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 31684759 — Pharmacodynamic Biomarker (PDY): Cyclic adenosine monophosphate
Study 31684759 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study 25074387 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 11942864 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 2657276 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TNS1 mRNA
Genes: TNS1; TNS
Study 29370333 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 29370333 — Surrogate Endpoint (SUR): Blood pressure
Study 25939484 — Safety Biomarker (SAF): miR-22
Genes: MIR22
Study 22343798 — Predictive Biomarker (PRD): NLRP1 mRNA
Genes: NLRP1; CARD7; DEFCAP; KIAA0926; NAC; NALP1
Study 10086532 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 8748680 — Pharmacodynamic Biomarker (PDY): Ataxin-3
Genes: ATXN3; ATX3; MJD; MJD1; SCA3
Study 8748680 — Pharmacodynamic Biomarker (PDY): Homovanillic acid
Study 31566129 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 31566129 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 30585454 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 30585454 — Predictive Biomarker (PRD): CORT mRNA
Genes: CORT; UNQ307/PRO350
Study 15870631 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 11833753 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 11833753 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 29915021 — Surrogate Endpoint (SUR): Blood pressure
Study 23774314 — Surrogate Endpoint (SUR): Blood pressure
Study 18781872 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 12401122 — Surrogate Endpoint (SUR): Blood pressure
Study 31395900 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 31395900 — Predictive Biomarker (PRD): DNA excision repair protein ERCC-1
Genes: ERCC1
Study 31395900 — Predictive Biomarker (PRD): ABCC1 mRNA
Genes: ABCC1; MRP; MRP1
Study 31395900 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MRP2
Genes: ABCC2; DJS; cMRP
Study 19363973 — Predictive Biomarker (PRD): ELK3 mRNA
Genes: ELK3; NET; SAP2
Study 30188231 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 23712757 — Predictive Biomarker (PRD): SLCO1A2 mRNA
Genes: SLCO1A2; OATP; OATP1; OATP1A2; SLC21A3
Study 20810374 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 20810374 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 16820345 — Surrogate Endpoint (SUR): Blood pressure
Study 26031828 — Predictive Biomarker (PRD): GATM mRNA
Genes: GATM; AGAT
Study 26031828 — Predictive Biomarker (PRD): GAMT mRNA
Genes: GAMT
Study 19555253 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19555253 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 15390343 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 11228295 — Surrogate Endpoint (SUR): Blood pressure
Study 2544829 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 21986208 — Predictive Biomarker (PRD): PTN mRNA
Genes: PTN; HBNF1; NEGF1
Study 9198048 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 30006299 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 27423055 — Surrogate Endpoint (SUR): Serum creatinine
Study 24332139 — Surrogate Endpoint (SUR): Blood pressure
Study 12212977 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 7794850 — Surrogate Endpoint (SUR): Bone mineral density
Study 29296811 — Safety Biomarker (SAF): ADORA2A
Genes: RDC8
Study 30348113 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study 20338560 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 20338560 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 15866563 — Surrogate Endpoint (SUR): Blood pressure
Study 1781563 — Surrogate Endpoint (SUR): Blood pressure
Study 30727929 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 8299664 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 8299664 — Surrogate Endpoint (SUR): Blood pressure
Study 2436183 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study 11235004 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 11235004 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 6529523 — Surrogate Endpoint (SUR): Blood pressure
Study 26993628 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 25276983 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study 17509068 — Surrogate Endpoint (SUR): Blood pressure
Study 2720192 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 27267614 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 19552750 — Surrogate Endpoint (SUR): Blood pressure
Study 16963348 — Predictive Biomarker (PRD): MNT mRNA
Genes: MNT; BHLHD3; ROX
Study 12359281 — Predictive Biomarker (PRD): CPZ mRNA
Genes: CPZ
Study 335490 — Surrogate Endpoint (SUR): Serum creatinine
Study 31278094 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study 31278094 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 31278094 — Safety Biomarker (SAF): Cyclin-dependent kinase inhibitor 1
Genes: CDKN1A
Study 31278094 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31278094 — Predictive Biomarker (PRD): TNF-related weak inducer of apoptosis
Genes: TNFSF12; APO3L; DR3LG; UNQ181/PRO207
Study 31278094 — Safety Biomarker (SAF): Peroxisome proliferator-activated receptor alpha
Genes: PPARA
Study 11491417 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 21859685 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 21859685 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 11193130 — Surrogate Endpoint (SUR): Blood pressure
Study 8473466 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study 29776559 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 26853286 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 24851690 — Predictive Biomarker (PRD): GGN mRNA
Genes: GGN
Study 24851690 — Predictive Biomarker (PRD): MIA mRNA
Genes: MIA
Study 20015788 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 10435729 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 10435729 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 2132424 — Surrogate Endpoint (SUR): Blood pressure
Study 29036816 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 29036816 — Safety Biomarker (SAF): BDNF
Study 26125443 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 20854436 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study 20854436 — Safety Biomarker (SAF): MMP-1
Genes: MMP1
Study 24691094 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 24691094 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 20647575 — Surrogate Endpoint (SUR): Blood pressure
Study 7759442 — Surrogate Endpoint (SUR): Blood pressure
Study 11305510 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 9772056 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 29912425 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 18043999 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 8970917 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 30661439 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 17377212 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 11302565 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study 21040375 — Surrogate Endpoint (SUR): Blood pressure
Study 16317124 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 18263663 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study 12483414 — Pharmacodynamic Biomarker (PDY): Major prion protein
Genes: PRNP; ALTPRP; PRIP; PRP
Study 10957749 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 28606219 — Surrogate Endpoint (SUR): Bone mineral density
Study 26206258 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 24002795 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 24002795 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 8732473 — Surrogate Endpoint (SUR): Bone mineral density
Study 28166785 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 21355003 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 15598915 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 19587607 — Surrogate Endpoint (SUR): Blood pressure
Study 15630183 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 15630183 — Predictive Biomarker (PRD): LPO mRNA
Genes: LPO; SAPX
Study 15630183 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study 26332900 — Surrogate Endpoint (SUR): Blood pressure
Study 20921467 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 20921467 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 19099714 — Predictive Biomarker (PRD): MAS1 mRNA
Genes: MAS1; MAS
Study 21148631 — Predictive Biomarker (PRD): PBX1 mRNA
Genes: PBX1; PRL
Study 6250823 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 31107542 — Predictive Biomarker (PRD): ERCC2 mRNA
Genes: ERCC2; XPD; XPDC
Study 31107542 — Predictive Biomarker (PRD): XPAC mRNA
Genes: XPA; XPAC
Study 31107542 — Predictive Biomarker (PRD): DNA excision repair protein ERCC-1
Genes: ERCC1
Study 26226960 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 20077733 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 31279073 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 25733627 — Surrogate Endpoint (SUR): Blood pressure
Study 22850357 — Safety Biomarker (SAF): MTHFR
Study 11004862 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 9232360 — Surrogate Endpoint (SUR): Blood pressure
Study 8450402 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31232639 — Predictive Biomarker (PRD): SIT1 mRNA
Genes: SIT1; SIT
Study 26704739 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study 19185287 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 11555831 — Safety Biomarker (SAF): MTHFR
Study 6113682 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 6113682 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study 6113682 — Predictive Biomarker (PRD): PPA1 mRNA
Genes: PPA1; IOPPP; PP
Study 17521392 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 17521392 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 17521392 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 17521392 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 17521392 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 3150019 — Safety Biomarker (SAF): Hydroxyphenylpyruvate dioxygenase
Genes: HPD; PPD
Study 24550168 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 15328178 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 15328178 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 8174988 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 8174988 — Safety Biomarker (SAF): CCKAR
Study 26260776 — Predictive Biomarker (PRD): TBX18 mRNA
Genes: TBX18
Study 26260776 — Predictive Biomarker (PRD): ADH1B mRNA
Genes: ADH1B; ADH2
Study 26260776 — Predictive Biomarker (PRD): PLAAT2 mRNA
Genes: PLAAT2; HRASLS2
Study 26260776 — Predictive Biomarker (PRD): GCNT3 mRNA
Genes: GCNT3
Study 26260776 — Predictive Biomarker (PRD): ALDH1A2 mRNA
Genes: ALDH1A2; RALDH2
Study 26260776 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-223
Genes: MIR223
Study 1657526 — Predictive Biomarker (PRD): CAST mRNA
Genes: CAST
Study 1657526 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study 29149745 — Predictive Biomarker (PRD): KCNN1 mRNA
Genes: KCNN1; SK
Study 27043535 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 27043535 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 23047592 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 2170884 — Surrogate Endpoint (SUR): Bone mineral density
Study 25271354 — Surrogate Endpoint (SUR): Blood pressure
Study 23782814 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 9703286 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53